Therapy of pemphigus.
Tóth
G G
GG
Department of Dermatology, University Hospital, The, Groningen, Netherlands. m.f.jonkman@derm.azg.nl
Jonkman
M F
MF
D001379:Azathioprine / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage; D003879:Dermatologic Agents / Q000008:administration & dosage*; D005938:Glucocorticoids / Q000008:administration & dosage; D006046:Gold / Q000008:administration & dosage; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*; D010392:Pemphigus / Q000188:drug therapy*; D010956:Plasmapheresis; D020551:Pulse Therapy, Drug; D016032:Randomized Controlled Trials as Topic
D003879:Dermatologic Agents; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D006046:Gold; D016572:Cyclosporine; D003520:Cyclophosphamide; D009173:Mycophenolic Acid; D001379:Azathioprine; D008727:Methotrexate